| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2007PNAS..10412434M |
| P356 | DOI | 10.1073/PNAS.0703510104 |
| P932 | PMC publication ID | 1941486 |
| P698 | PubMed publication ID | 17640915 |
| P5875 | ResearchGate publication ID | 6197546 |
| P50 | author | Stefan Kaufmann | Q2336447 |
| Hans-Willi Mittrücker | Q47087578 | ||
| Ulrich Steinhoff | Q54300356 | ||
| P2093 | author name string | Hans-Willi Mittrücker | |
| Doris Lazar | |||
| Anne Köhler | |||
| Peggy Mex | |||
| Marion Krause | |||
| Delia Miekley | |||
| P2860 | cites work | Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity | Q28269283 |
| Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes | Q33591737 | ||
| Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice | Q33769144 | ||
| Macrophage activation and resistance to pulmonary tuberculosis | Q33902753 | ||
| Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice | Q34001403 | ||
| Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. | Q34007030 | ||
| CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis | Q34008225 | ||
| Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein | Q34034191 | ||
| Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization | Q34120343 | ||
| BCG: the challenge continues | Q34246761 | ||
| An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis | Q34492775 | ||
| Preferential localization of effector memory cells in nonlymphoid tissue | Q34514330 | ||
| Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis | Q34527217 | ||
| Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen | Q35070693 | ||
| Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. | Q35097395 | ||
| Temporal development of resistance to pulmonary tuberculosis in Swiss albino mice | Q36270641 | ||
| The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice | Q36376221 | ||
| Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection | Q36399636 | ||
| Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice | Q36399929 | ||
| Tuberculosis: back on the immunologists' agenda | Q36450881 | ||
| Th1 memory: implications for vaccine development | Q36528942 | ||
| Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection | Q37347705 | ||
| Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens | Q39171860 | ||
| CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis | Q44372342 | ||
| Organ-specific CD4+ T cell response during Listeria monocytogenes infection | Q44880331 | ||
| Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses | Q45204458 | ||
| Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. | Q47423311 | ||
| Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes. | Q52026591 | ||
| Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. | Q52927291 | ||
| Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. | Q52936537 | ||
| MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis. | Q52963484 | ||
| Envisioning future strategies for vaccination against tuberculosis. | Q53230123 | ||
| Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis. | Q53938703 | ||
| Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice | Q73389486 | ||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| P304 | page(s) | 12434-12439 | |
| P577 | publication date | 2007-07-18 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis | |
| P478 | volume | 104 |
| Q90308868 | A Xenopus tadpole alternative model to study innate-like T cell-mediated anti-mycobacterial immunity |
| Q37431320 | A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93. |
| Q27349862 | A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo |
| Q37374704 | A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire |
| Q34513982 | A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis |
| Q36103177 | A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis |
| Q35889153 | A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults |
| Q38711772 | A review of clinical models for the evaluation of human TB vaccines |
| Q38659442 | A role for IL-18 in protective immunity against Mycobacterium tuberculosis |
| Q38899894 | Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin |
| Q59050547 | Accelerating the secondary immune response by inactivating CD4+CD25+ T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis |
| Q37410524 | Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis |
| Q52597636 | Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults. |
| Q42576378 | Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model |
| Q30375962 | Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model |
| Q37438123 | An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy |
| Q92538491 | An Inflammatory Story: Antibodies in Tuberculosis Comorbidities |
| Q33595443 | Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study |
| Q37500859 | Antigen-Specific IFN-γ Responses Correlate with the Activity of M. tuberculosis Infection but Are Not Associated with the Severity of Tuberculosis Disease |
| Q40060240 | Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population |
| Q46640818 | Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis |
| Q46854258 | Association of quantitative interferon-γ responses with the progression of naturally acquired Mycobacterium bovis infection in wild European badgers (Meles meles). |
| Q34566311 | Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice |
| Q35778676 | B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B. |
| Q28740546 | B cell depletion reduces the number of autoreactive T helper cells and prevents glucose-6-phosphate isomerase-induced arthritis |
| Q34097601 | BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model |
| Q37402055 | Biomarkers for tuberculosis disease activity, cure, and relapse |
| Q36305994 | Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection |
| Q39473407 | Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination |
| Q36951532 | CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease |
| Q33988111 | CD4 and CD8 T-cell responses to mycobacterial antigens in African children |
| Q64937268 | CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial. |
| Q35139265 | CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis |
| Q43107636 | Can we change the way we look at BCG vaccine? |
| Q64256617 | Cell Differentiation Degree as a Factor Determining the Role for Different T-Helper Populations in Tuberculosis Protection |
| Q41926056 | Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial |
| Q47361714 | Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker. |
| Q31028998 | Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination |
| Q91130202 | Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination |
| Q83716891 | Characterization of the renal CD4+ T-cell response in experimental autoimmune glomerulonephritis |
| Q97067669 | Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis |
| Q41472120 | Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh |
| Q43579593 | Combination of host susceptibility and Mycobacterium tuberculosis virulence define gene expression profile in the host |
| Q42324485 | Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis |
| Q51961303 | Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites. |
| Q37350429 | Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response |
| Q34139968 | Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS. |
| Q37548125 | Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection |
| Q34251506 | Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis |
| Q44391246 | Divergence of immunologic and protective responses of different BCG strains in a murine model |
| Q35887146 | Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine |
| Q37544959 | Efficient activation of human T cells of both CD4 and CD8 subsets by urease-deficient recombinant Mycobacterium bovis BCG that produced a heat shock protein 70-M. tuberculosis-derived major membrane protein II fusion protein |
| Q36672533 | Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone |
| Q93184501 | Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells |
| Q40450707 | Enhanced protective efficacy against tuberculosis provided by a recombinant urease deficient BCG expressing heat shock protein 70-major membrane protein-II having PEST sequence. |
| Q79711919 | Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis |
| Q44070977 | Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route |
| Q37907518 | Fact and fiction in tuberculosis vaccine research: 10 years later |
| Q37846876 | For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection |
| Q88874314 | Friends and foes of tuberculosis: modulation of protective immunity |
| Q26849399 | Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis |
| Q35940636 | Heparin-binding hemagglutinin induces IFN-γ(+) IL-2(+) IL-17(+) multifunctional CD4(+) T cells during latent but not active tuberculosis disease |
| Q58693696 | Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection |
| Q37461371 | Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects |
| Q37275906 | Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function |
| Q36981662 | How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis |
| Q35568440 | ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis |
| Q43740030 | Identification of HLA-DR4-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening and DNA vaccination |
| Q37186665 | Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection |
| Q37737607 | Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? |
| Q38015625 | Immune markers and correlates of protection for vaccine induced immune responses |
| Q26829220 | Immune vulnerability of infants to tuberculosis |
| Q91782506 | Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
| Q33518452 | Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection |
| Q33488354 | Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice |
| Q38670391 | Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins |
| Q56774465 | Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis |
| Q37075418 | Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis |
| Q35934842 | Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination |
| Q33518560 | Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection |
| Q33348739 | Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations |
| Q34738803 | Immunostimulatory activity of major membrane protein II from Mycobacterium tuberculosis |
| Q49161794 | Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial. |
| Q38192925 | In search of a new paradigm for protective immunity to TB |
| Q58397026 | In vitro analysis of antigen induced T cell-monocyte conjugates by imaging flow cytometry |
| Q26741365 | In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy |
| Q92239476 | Inactivated Lactobacillus plantarum Carrying a Surface-Displayed Ag85B-ESAT-6 Fusion Antigen as a Booster Vaccine Against Mycobacterium tuberculosis Infection |
| Q58762751 | Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4 T cell population following BCG immunisation |
| Q28508390 | Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior |
| Q34479089 | Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth |
| Q40497124 | Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism |
| Q36303844 | Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis |
| Q33715452 | Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin |
| Q38031924 | Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology |
| Q82226022 | Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c) |
| Q90859101 | Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice |
| Q37054583 | Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine |
| Q37259224 | MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment |
| Q53096344 | Mtb9.9 protein family: an immunodominant antigen family of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice. |
| Q92246549 | Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges |
| Q44753732 | Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection |
| Q33839055 | Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice |
| Q84912104 | Murine immune responses to oral BCG immunization in the presence or absence of prior BCG sensitization |
| Q30399629 | Mycobacterial PE/PPE proteins at the host-pathogen interface |
| Q28083909 | Mycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human Tuberculosis |
| Q36513451 | Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice |
| Q84592120 | Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis |
| Q33791961 | Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. |
| Q37309251 | Novel strategies to identify biomarkers in tuberculosis |
| Q30363188 | Novel vaccination strategies against tuberculosis. |
| Q34438532 | Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune response |
| Q33979892 | Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis |
| Q38435794 | Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection. |
| Q33573078 | Polyclonal activation of naïve T cells by urease deficient-recombinant BCG that produced protein complex composed of heat shock protein 70, CysO and major membrane protein-II |
| Q39397075 | Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants |
| Q27024526 | Prime-boost approaches to tuberculosis vaccine development |
| Q35231023 | Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells |
| Q46924873 | Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells |
| Q28084282 | Quest for correlates of protection against tuberculosis |
| Q57128430 | Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis |
| Q38696320 | Relevance of bovine tuberculosis research to the understanding of human disease: historical perspectives, approaches, and immunologic mechanisms |
| Q35824421 | Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice. |
| Q33900380 | Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells |
| Q33539882 | Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis |
| Q41487951 | Severe Tuberculosis in Humans Correlates Best with Neutrophil Abundance and Lymphocyte Deficiency and Does Not Correlate with Antigen-Specific CD4 T-Cell Response |
| Q38273050 | Shaping the CD4+ memory immune response against tuberculosis: the role of antigen persistence, location and multi-functionality. |
| Q41775340 | Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns |
| Q37365050 | Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis |
| Q28603191 | Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study |
| Q33948002 | Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge |
| Q26851326 | Systems biology in vaccine design |
| Q37568423 | T cells in mycobacterial infection and disease |
| Q53510500 | TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis. |
| Q27327288 | Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis |
| Q26774207 | Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers |
| Q37476108 | The European effort towards the development of mucosal vaccines for poverty-related diseases |
| Q93062702 | The Humoral Immune Response to BCG Vaccination |
| Q60441795 | The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-γ response |
| Q37548692 | The candidate TB vaccine, MVA85A, induces highly durable Th1 responses |
| Q35200725 | The frequencies of IFNγ+IL2+TNFα+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON® gold in-tube response in a prospective study of healthy indian adolescents |
| Q52674677 | The immune characterization of interferon-β responses in tuberculosis patients. |
| Q39753551 | The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin |
| Q35859543 | The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda |
| Q39322060 | The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects |
| Q33950119 | The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults |
| Q40064445 | The role of ADAM17 in the T-cell response against bacterial pathogens |
| Q37173259 | The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells |
| Q93052065 | Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection |
| Q103760781 | Tuberculosis vaccination needs to avoid 'decoy' immune reactions |
| Q26782022 | Tuberculosis vaccines and prevention of infection |
| Q28390218 | Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool |
| Q22242669 | Tuberculosis vaccines: beyond bacille Calmette-Guerin |
| Q35039934 | Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis |
| Q37401457 | Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis. |
| Q26992233 | Vaccines against tuberculosis: where are we and where do we need to go? |
| Q35666220 | Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis |
Search more.